Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Divalproex Sodium in Bipolar Depression with Alcohol Abuse
NCT00204503Phase 2Withdrawn
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Jun 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of divalproex sodium in bipolar disorder (BD) and alcohol dependence, sponsored by The University of Texas Medical Branch at Galveston. Primary endpoints: Percent change in Montgomery-Asberg Depression Rating Scale, Percent of days heavy drinking and 1 more. Planned start Jun 2003; status: withdrawn.
02
Drugs
divalproex sodium
03
Conditions
bipolar disorder (BD)alcohol dependence
Beyond the preview
Go deeper on NCT00204503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00204503.